Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 33 sec ago

MD Anderson, Astellas Pharma Sign Option Agreement for Monoclonal Antibody Drug Targeting Acute Myeloid Leukemia

Fri, 04/03/2015 - 16:12
TOKYO and HOUSTON, April 3, 2015 -- (Healthcare Sales & Marketing Network) -- Astellas Pharma Inc. (TSE:4503) and The University of Texas MD Anderson Cancer Center today announced the signing of an option agreement to research and develop a new treatment ...
Biopharmaceuticals, Oncology, Licensing
Astellas Pharma, MD Anderson, acute myeloid leukemia

Bruker Announces FDA Clearance for Second, Expanded Claim for the MALDI Biotyper CA System

Fri, 04/03/2015 - 16:07
BILLERICA, Mass.--(Healthcare Sales & Marketing Network)--Bruker (BRKR) today announced that it has received 510(k) clearance from the US Food and Drug Administration for library and methods expansion for the MALDI Biotyper CA System, sold in the United St...
Diagnostics, FDA
Bruker Corp, MALDI BioTyper

Augmenix Announces FDA Clearance of SpaceOAR(R) System

Thu, 04/02/2015 - 15:43
WALTHAM, Mass.--(Healthcare Sales & Marketing Network)--Augmenix, Inc., a privately held company developing minimally invasive hydrogel products to improve outcomes following cancer radiotherapy, today announced FDA clearance of the SpaceOAR® System, t...
Devices, Oncology, FDA
Augmenix, SpaceOAR, prostate cancer, radiotherapy

Ethicon’s HARMONIC FOCUS(R)+ Shears Now Proven to Produce Vessel Seal Strength Equivalent to Advanced Bipolar Devices

Thu, 04/02/2015 - 15:35
Ultrasonic device known for meticulous dissection now produces lower tissue temperature and less thermal damage critical when working near nerves CINCINNATI--(Healthcare Sales & Marketing Network)--Ethicon*, a leading global provider of medical devices,...
Devices, Surgery
Ethicon, HARMONIC FOCUS, hemostasis

Perosphere Receives FDA Fast Track Designation for Investigational Anticoagulant Reversal Agent PER977

Thu, 04/02/2015 - 15:24
DANBURY, Conn.--(Healthcare Sales & Marketing Network)--Perosphere Inc. today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for PER977, an investigational anticoagulant reversal agent. The FDA established the ...
Biopharmaceuticals, FDA
Perosphere, PER977, anticoagulant, anticoagulant reversal

Boston Scientific Agrees to Acquire Xlumena

Wed, 04/01/2015 - 20:54
MARLBOROUGH, Mass. and MOUNTAIN VIEW, Calif., April 1, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) announces that it has signed a definitive agreement to acquire Xlumena, Inc., a venture-backed medical device comp...
Devices, Interventional, Mergers & Acquisitions
Boston Scientific, Xlumena, Endoscopic Ultrasound, pancreatic pseudocyst

AMAG Pharmaceuticals Announces New Management Appointments

Wed, 04/01/2015 - 20:51
Company Adds New External Affairs Function WALTHAM, Mass., April 1, 2015 -- (Healthcare Sales & Marketing Network) -- AMAG Pharmaceuticals, Inc. (AMAG) today announced new management appointments which expand the company's ability to engage with externa...
Biopharmaceuticals, Personnel
AMAG Pharmaceuticals

NuVasive Announces Leadership Transition

Wed, 04/01/2015 - 16:03
Gregory T. Lucier Appointed Chairman and Interim Chief Executive Officer Alex V. Lukianov Steps Down as Chairman and Chief Executive Officer Company Anticipates 2015 First Quarter Revenue Will Exceed $190 Million, Including More Than $2 Million of Cu...
Devices, Orthopaedic, Neurosurgery, Personnel
NuVasive, Maximum Access Surgery, spine surgery

Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations

Wed, 04/01/2015 - 15:52
TEL AVIV, Israel, April 1, 2015 -- (Healthcare Sales & Marketing Network) -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy...
Biopharmaceuticals, Gastroenterology, Personnel
Galmed Pharmaceuticals, aramchol

Teva Announces FDA Approval of ProAir(R) RespiClick

Wed, 04/01/2015 - 15:50
First Breath-Actuated Dry-Powder Short-Acting Beta-Agonist (SABA) Inhaler to be Approved by the FDA JERUSALEM--(Healthcare Sales & Marketing Network)--Teva Pharmaceutical Industries Ltd., (TEVA) today announced that the U.S. Food and Drug Administration...
Biopharmaceuticals, Drug Delivery, FDA
Teva Pharmaceutical, ProAir, RespiClick, albuterol

Iroko Pharmaceuticals Appoints New Member to Company’s Board of Directors

Wed, 04/01/2015 - 15:46
Industry veteran brings more than 30 years of experience to support Company’s growing low dose NSAID franchise PHILADELPHIA--(Healthcare Sales & Marketing Network)--Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advan...
Biopharmaceuticals, Personnel
Iroko Pharmaceuticals, SoluMatrix, NSAID

ImmunoGen, Inc. Appoints Anna Berkenblit, MD, MMSc Vice President and Chief Medical Officer

Wed, 04/01/2015 - 15:40
WALTHAM, Mass.--(Healthcare Sales & Marketing Network)--ImmunoGen, Inc. (IMGN), a biotechnology company that develops targeted anticancer therapies using its antibody-drug conjugate (ADC) technology, today announced the appointment of Anna Berkenblit, MD, ...
Biopharmaceuticals, Oncology, Personnel
ImmunoGen, Kadcyla

InVivo Therapeutics Announces New Clinical Trial Site for Neuro-Spinal Scaffold

Wed, 04/01/2015 - 15:38
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that UC Davis Medical Center in Sacramento, CA has been added as a clinical site in the company’s ongoing IDE pilot study of its Neuro-Spina...
Devices, Neurosurgery, Neurology
InVivo Therapeutics, Neuro-Spinal Scaffold

Corium Announces Appointment of Eric H. Bjerkholt to Board of Directors

Wed, 04/01/2015 - 15:32
MENLO PARK, Calif., April 1, 2015 -- (Healthcare Sales & Marketing Network) -- Corium International, Inc. (CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, ...
Biopharmaceuticals, Drug Delivery, Personnel
Corium International, Corplex

Medela Launches Product Line to Support Individualized Care For Negative Pressure Wound Therapy Patients

Tue, 03/31/2015 - 15:04
MCHENRY, Ill., March 31, 2015 -- (Healthcare Sales & Marketing Network) -- Medela has announced the addition of the Invia® Motion™-15-Days and Invia® Motion™-Endure personal pumps to its Negative Pressure Wound Therapy (NPWT) portfolio of products...
Devices, Wound Care, Product Launch
Medela, Invia Motion, NPWT, Negative Pressure Wound Therapy

Tyrogenex, Xcovery Appoint Michael Webb as President and Chief Executive Officer

Tue, 03/31/2015 - 14:03
PALM BEACH GARDENS, Fla.--(Healthcare Sales & Marketing Network)--Tyrogenex and Xcovery, two privately held companies focused on the development of next-generation targeted therapeutics for cancer and ophthalmology, today announced the appointment of Micha...
Biopharmaceuticals, Ophthalmology, Oncology, Personnel
Xcovery, Tyrogenex

GW Pharmaceuticals Initiates First Phase 3 Pivotal Trial for Epidiolex in Dravet Syndrome

Tue, 03/31/2015 - 13:57
LONDON, March 31, 2015 -- (Healthcare Sales & Marketing Network) -- GW Pharmaceuticals plc (GWPH) (GWP.L) ("GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing...
Biopharmaceuticals, Neurology
GW Pharmaceuticals, cannabinoid, Epidiolex, Dravet syndrome

Orthofix International Secures Option to Acquire eNeura, Inc.

Tue, 03/31/2015 - 13:52
Orthofix Provides eNeura $15 Million Collateralized Loan to Support Commercialization of SpringTMS LEWISVILLE, Texas & BALTIMORE, Md.--(Healthcare Sales & Marketing Network)--Orthofix International N.V. (OFIX) (the Company), a diversified, global medica...
Devices, Neurology, Mergers & Acquisitions
Orthofix International, eNeura , Transcranial Magnetic Stimulation, SpringTMS

EDP Biotech Signs Distribution Partnership Agreements for ColoMarker(R) Abroad

Tue, 03/31/2015 - 13:44
ColoMarker(R) Is a Simple, Sensitive Blood Test That Aids in Detection of Early Stage Colorectal Cancer KNOXVILLE, TN--(Healthcare Sales & Marketing Network) - EDP Biotech Corporation (EDP), a global in vitro diagnostic innovator of a simple blood-based...
Diagnostics, Oncology, Distribution
EDP Biotech, ColoMarker, colorectal cancer, CA11-19

The Medicines Company Receives European Commission Approval for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(R) (oritavancin) and RAPLIXA(TM) (sealant powder)

Mon, 03/30/2015 - 13:42
Marketing authorization valid in 31 countries of the European Economic Area KENGREXAL™ is the first and only intravenous antiplatelet agent that provides immediate, consistent, and rapidly reversible P2Y12 inhibition ORBACTIV® is the only single-...
Biopharmaceuticals, Regulatory
The Medicines Company, KENGREXAL, ORBACTIV, RAPLIXA

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong